FDA Approved: FYCOMPA — Supplemental Application (Eisai Inc.)

View source ↗

Summary

FDA approved Eisai Inc.'s supplemental application for FYCOMPA (perampanel). This action approves a supplemental indication/labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

SUPPL AP for FYCOMPA (PERAMPANEL)